Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab ... of first-in-class therapies for the disorder. Data reported at the Kidney Week 2024 congress in San ...

To maintain data integrity, outlier predictions were reviewed and either explained or excluded. Ethereum adoption continues to grow thanks to NFTs, DeFi, tokenized assets and Layer-2 scaling. Its ...